XML 26 R13.htm IDEA: XBRL DOCUMENT v3.23.3
EARNINGS (LOSS) PER SHARE
9 Months Ended
Sep. 30, 2023
EARNINGS (LOSS) PER SHARE  
EARNINGS (LOSS) PER SHARE

NOTE 6 – EARNINGS (LOSS) PER SHARE

Basic earnings (loss) per share is calculated by dividing the net income (loss) by the weighted average number of shares of Common Stock outstanding during each period.

Diluted earnings per share is calculated by dividing the net income by the weighted-average number of shares of Common Stock outstanding during each period increased to include the number of additional shares of Common Stock that would have been outstanding if the potentially dilutive shares had been issued.

In computing diluted earnings per share, basic earnings per share are adjusted to take into account the potential dilution that could occur upon: (i) the exercise of options granted under employee stock compensation plans using the treasury stock method; (ii) the exercise of warrants using the treasury stock method; and (iii) the conversion of the convertible notes using the “if-converted” method.

Basic and diluted net earnings (loss) per share attributable to common stockholders were calculated as follows:

Three Months Ended September 30, 

Nine Months Ended September 30, 

(In thousands, except share data)

2023

2022

2023

2022

Numerator:

Net income (loss)

$

(1,852)

$

(3,567)

$

14,356

$

(11,187)

Add:

Financial expenses of 2024 Notes*

$

(1,766)

$

(1,610)

Net income (loss) for diluted calculation

$

(3,618)

$

(3,567)

$

12,746

$

(11,187)

Denominator:

Weighted average shares of Common Stock outstanding for basic calculation

72,281,681

49,498,105

65,811,506

47,582,733

Weighted average dilutive effect of 2024 Notes

11,500,998

13,981,660

Weighted average dilutive effect of stock options

1,247,115

Weighted average shares of Common Stock outstanding for diluted calculation

83,782,679

49,498,105

81,040,281

47,582,733

* Financial expenses on 2024 Notes consists of add back of financial expense incurred during the period and inclusion of make-whole interest payments that will be incurred upon conversion.

Diluted earnings (loss) per share do not include 19,429,910 and 18,399,260 shares of Common Stock underlying outstanding stock options and warrants of the Company for the three and nine months ended September 30, 2023, respectively, because the effect would be anti-dilutive.

Diluted earnings (loss) per share do not include 33,922,624 and 33,295,154 shares of Common Stock underlying outstanding stock options, warrants and the 2024 Notes for the three and nine months ended September 30, 2022, respectively, because the effect would be anti-dilutive.